Baicalein Inhibits Orthotopic Human Non-Small Cell Lung Cancer Xenografts via Src/Id1 Pathway

Zhengxiao Zhao1, Baojun Liu1,2, Jing Sun1,2

  • 1The Department of Integrative Medicine, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai 200040, China.

Insights

Baicalein effectively reduces non-small cell lung cancer (NSCLC) tumor growth by targeting the Src/Id1 pathway. This natural compound inhibits key proteins involved in tumor progression and blood vessel formation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality globally.
  • Inhibitor of differentiation 1 (Id1) is implicated in cancer development and serves as a potential therapeutic target.
  • Understanding novel therapeutic strategies for NSCLC is crucial.

Purpose of the Study:

  • To investigate the antitumor effects of baicalein in an orthotopic NSCLC model.
  • To elucidate the molecular mechanisms underlying baicalein's action, focusing on the Src/Id1 pathway.

Main Methods:

  • Establishment of an orthotopic NSCLC xenograft model using A549 cells in athymic nude mice.
  • Administration of baicalein and evaluation of antitumor effects via Micro-CT imaging.
  • Analysis of protein expression (Id1, EMT markers, VEGF-A, E-cadherin) and Src phosphorylation using Western blot.

Main Results:

  • Baicalein significantly reduced tumor volume in the orthotopic NSCLC model.
  • Baicalein suppressed Id1 expression, epithelial-to-mesenchymal transition (EMT) markers (N-Cadherin, vimentin), and VEGF-A.
  • Baicalein treatment led to upregulation of epithelial markers (E-cadherin) and inhibition of Src phosphorylation.

Conclusions:

  • Baicalein exhibits significant antitumor activity against human NSCLC xenografts.
  • The study demonstrates that baicalein targets the Src/Id1 pathway to inhibit tumor growth, EMT, and angiogenesis.
  • Baicalein represents a promising therapeutic agent for NSCLC treatment.

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.0K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.0K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.8K
Other Glycolytic Pathways01:24

Other Glycolytic Pathways

The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...
860
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.8K